U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Drug Topics: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update - April 26, 2021
  1. About FDA

FDA Drug Topics: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update - April 26, 2021

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On Monday, April 26, 2021, CDER's Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update. This webinar will discuss how the Office of Orphan Products Development (OOPD) advances the development of products for rare diseases. The webinar will also review the history of OOPD, the Orphan Drug Act, and other core programs within OOPD.

The Adobe Connect room for this webinar can accommodate 1500 participants.  If the room is full when you attempt to enter, please note that the recording of the webinar will be available on our Division of Drug Information Webinars webpage later this week and will also be available as a Home Study course providing CE credit in a few weeks.

Register Here: https://collaboration.fda.gov/ddi042721/event/registration.html

Activity Outline and Continuing Education Information: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update (PDF - 167KB)


If you have never attended an Adobe Connect meeting before (Google Chrome (preferred) or Firefox 43 or higher):

Test your connection: Adobe Connect Diagnostic Test

Get a quick overview: Discover Adobe Connect Solutions

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

 

Resources For You

 

 

 

Back to Top